
    
      The multi-centre COVIDOC study will evaluate the efficacy and safety of the use of
      hydroxychloroquine (10 days) combined with azithromycin (5 days) compared to
      hydroxychloroquine (10 days) in the the clinical evolution by the ordinal scale of 7 points
      in adults hospitalized outside Intensive care unit with pneumonia caused by infection by the
      SARS-CoV2 virus in France.
    
  